From the microarray results, the three genes (α-2-macroglobulin (A2M), collagen type II alpha-1 (Col2A1), melanoma inhibitory activity-1 (MIA)) showing the highest upregulation or fold change were selected for validation by means of RT-PCR. This evidence concerns the gene A2M and melanoma.